Cyclacel Pharmaceuticals, Inc. (CYCC) Posts Q2 Loss of 6c/Share
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) reported Q2 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
